Related Experiment Video
Updated: Jun 3, 2026

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques
Published on: June 1, 2016
Microglia demonstrate age-dependent interaction with amyloid-β fibrils
Angela Marie Floden1, Colin Kelly Combs
1Department of Pharmacology, Physiology and Therapeutics, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND 58203-9037, USA.
Abstract:
Alzheimer's disease (AD) is an age-associated disease characterized by increased accumulation of extracellular amyloid-β (Aβ) plaques within the brain. Histological examination has also revealed profound microglial activation in diseased brains often in association with these fibrillar peptide aggregates. The paradoxical presence of increased, reactive microglia yet accumulating extracellular debris suggests that these cells may be phagocytically compromised during disease. Prior work has demonstrated that primary microglia from adult mice are unable to phagocytose fibrillar Aβ1-42 in vitro when compared to microglia cultured from early postnatal animals. These data suggest that microglia undergo an age-associated decrease in microglial ability to interact with Aβ fibrils. In order to better define a temporal profile of microglia-Aβ interaction, acutely isolated, rather than cultured, microglia from 2 month, 6 month, and postnatal day 0 C57BL/6 mice were compared. Postnatal day 0 microglia demonstrated a CD47 dependent ability to phagocytose Aβ fibrils that was lost by 6 months. This corresponded with the ability of postnatal day 0 but not adult microglia to decrease Aβ immunoreactive plaque load from AD sections in vitro. In spite of limited Aβ uptake ability, adult microglia had functional phagocytic uptake of bacterial bioparticles and demonstrated the ability to adhere to both Aβ plaques and in vitro fibrillized Aβ. These data demonstrate a temporal profile of specifically Aβ-microglia interaction with a critical developmental period at 6 months in which cells remain able to interact with Aβ fibrils but lose their ability to phagocytose it.
Insights
Microglia in Alzheimer's disease (AD) lose their ability to clear amyloid-beta (Aβ) plaques with age. This study reveals a critical developmental window around 6 months where this phagocytic function is lost, impacting AD progression.
Area of Science:
- Neuroscience
- Immunology
- Aging Research
Background:
- Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) plaque accumulation and microglial activation.
- Microglia, the brain's immune cells, appear dysfunctional in AD, with reduced ability to clear Aβ.
- Previous studies suggest an age-associated decline in microglial phagocytosis of Aβ.
Purpose of the Study:
- To define the temporal profile of microglial interaction with amyloid-beta (Aβ) fibrils.
- To investigate the age-dependent changes in microglial phagocytic capacity for Aβ.
- To identify critical developmental periods influencing microglial Aβ clearance.
Main Methods:
- Acutely isolated microglia from mice at postnatal day 0, 2 months, and 6 months were used.
- Microglial phagocytosis of Aβ fibrils and bacterial bioparticles was assessed in vitro.
- The ability of microglia to reduce Aβ plaque load in AD brain sections was evaluated.
Main Results:
- Postnatal day 0 microglia effectively phagocytosed Aβ fibrils in a CD47-dependent manner.
- This phagocytic ability was lost by 6 months of age in mice.
- Adult microglia retained phagocytic function for bacterial bioparticles but showed impaired Aβ uptake, despite adhering to Aβ plaques.
Conclusions:
- There is a specific age-associated decline in microglial phagocytosis of Aβ fibrils.
- A critical developmental window around 6 months of age exists where microglia lose Aβ phagocytic function.
- Understanding this temporal profile is crucial for developing therapeutic strategies targeting microglial function in Alzheimer's disease.
More Related Videos
10:40Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
Published on: October 27, 2019
09:33Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology